The Centre on Thursday, April 15, has granted permission to Mumbai-based Haffkine Bio Pharma to manufacture Bharat Biotech's Covaxin within a year.
This is the first time that another pharma company, which was not part of the vaccine development process, is being given the technology.
The Maharashtra government made the announcement regarding the approval through their official Twitter handle.
Moreover, Chief Minister Uddhav Thackeray also thanked Prime Minister Narendra Modi for allowing Maharashtra government-owned Haffkine Institute to manufacture the vaccines at a time when the state and nation are reeling under the second wave of coronavirus.
"The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis from Hyderabad-based Bharat Biotech Corporation," the Maharashtra Chief Minister's Office tweeted.
Maharashtra Chief Minister Uddhav Thackeray had earlier requested the centre to allow the Haffkine Institute to produce Covaxin. In a video conference with PM Modi held in March, Thackeray had raised the issue and requested PM Modi to allow the state-owned pharma company to manufacture the vaccine.
In January, Haffkine sought the nod from the ICMR for technology transfer. In March, it again sought permission and said that in case it is not granted the permission to manufacture the vaccine, it can 'fill and finish' operations of the Covid vaccine, where it will only fill vaccines in bottles and make them ready for dispatch.
Share
Tweet
